Related references
Note: Only part of the references are listed.Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers
H. Zou et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding
Michelle Giles et al.
ANTIVIRAL THERAPY (2011)
Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
E. Jenny Heathcote et al.
GASTROENTEROLOGY (2011)
Natural history of chronic hepatitis B in Euro-Mediterranean and African Countries
Stephanos J. Hadziyannis
JOURNAL OF HEPATOLOGY (2011)
A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection
Guo-Rong Han et al.
JOURNAL OF HEPATOLOGY (2011)
Lamivudine in Late Pregnancy to Interrupt In Utero Transmission of Hepatitis B Virus A Systematic Review and Meta-Analysis
Zhongjie Shi et al.
OBSTETRICS AND GYNECOLOGY (2010)
Antiretroviral Treatment in Pregnancy: A Six-Year Perspective on Recent Trends in Prescription Patterns, Viral Load Suppression, and Pregnancy Outcomes
Silvia Baroncelli et al.
AIDS PATIENT CARE AND STDS (2009)
A review of nucleoside reverse transcriptase inhibitor use to prevent perinatal transmission of HIV
Diana Nurutdinova et al.
EXPERT OPINION ON DRUG SAFETY (2009)
2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B
Yun-Fan Liaw et al.
GASTROENTEROLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?
C. Foster et al.
HIV MEDICINE (2009)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
Patrick Marcellin et al.
JOURNAL OF HEPATOLOGY (2009)
Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study
W. -M. Xu et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Adverse Effects of Tenofovir Use in HIV-Infected Pregnant Women and their Infants
Diana Nurutdinova et al.
ANNALS OF PHARMACOTHERAPY (2008)
Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: Summary of pharmacokinetics and biological and virological effects
Koen K. A. Van Rompay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus
Julia B. Purdy et al.
JOURNAL OF PEDIATRICS (2008)
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Patrick Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: Impact on bone mineral density in HIV-infected children
Rachel I. Gafni et al.
PEDIATRICS (2006)
Natural history of hepatitis B virus infection in children
MH Chang
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
Share Paper
